DG INNOVATE PLC Logo

DG INNOVATE PLC

Develops sustainable technologies for electric mobility and energy storage solutions.

DGI | IL

Overview

Corporate Details

ISIN(s):
GB00BMZ3D204 (+2 more)
LEI:
21380058VQBP76M7TN11
Country:
United Kingdom
Address:
15 VICTORIA MEWS COTTINGLEY BUSINESS PARK, BD16 1PY BINGLEY

Description

DG Innovate PLC is an advanced research and development company pioneering sustainable and environmentally considerate technologies for electric mobility and energy storage. The company focuses on developing proprietary solutions, including ultra-high performance electric drive systems and advanced energy storage materials. Its key product portfolio features the Pareta® e-drive, a novel motor technology designed for electric vehicles. DG Innovate's work targets the sustainable transportation and energy sectors, leveraging its expertise in material science and electric motor innovation to create next-generation solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2020-11-05 08:00
Further re the Acquisition of 75% of DT Ultravert
English HTML 13.3 KB
2020-10-08 10:55
Option Surrender and Issue of Replacement Options
English HTML 36.0 KB
2020-10-05 08:00
Proposed sale of Kansas Land Leases and equipment
English HTML 11.4 KB
2020-10-01 12:41
Further re the Acquisition of DT Ultravert
English HTML 15.4 KB
2020-09-30 08:00
Board Changes & Acquisition of Deferred Shares
English HTML 14.1 KB
2020-09-11 18:42
Interim Results to 30 June 2020
English PDF 240.3 KB
2020-09-11 18:38
Annual Report and Accounts 2019
English PDF 784.6 KB
2020-09-10 14:30
Interim Results for the six months to 30 June 2020
English HTML 115.0 KB
2020-09-10 14:15
Final Results for the Year Ended 31 December 2019
English HTML 356.2 KB
2020-07-07 15:00
Update on Acquisition
English HTML 12.7 KB
2020-06-22 17:45
Further re Application for Lifting of Suspension
English HTML 9.0 KB
2020-06-17 08:00
Financial Adviser Appointment
English HTML 10.0 KB
2020-06-17 08:00
Director/PDMR Shareholding
English HTML 20.5 KB
2020-06-12 08:00
Fundraising & Lifting of Suspension Application
English HTML 13.3 KB
2020-05-27 08:00
Acquisition of DTU and Kansas Nitrogen Reserves
English HTML 22.4 KB

Automate Your Workflow. Get a real-time feed of all DG INNOVATE PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DG INNOVATE PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DG INNOVATE PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.